Evidence map›Paper›PMID 32657070›Full record

ArticleJournal of clinical neurology (Seoul, Korea)2020

Determination of Brain Death/Death by Neurologic Criteria in Countries in Asia and the Pacific.

Ariane Lewis, Jordan Liebman, Azza Bakkar, Elana Kreiger-Benson, Andrew Kumpfbeck, Sam D Shemie, Gene Sung, Sylvia Torrance, David Greer

Abstract read
In one paragraph

Article in Journal of clinical neurology (Seoul, Korea), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ariane LewisNYU Langone Medical Center, New York, NY, USA. ariane.kansas.lewis@gmail.com.ORCID https://orcid.org/0000-0002-0756-7320
Jordan LiebmanNYU School of Medicine, New York, NY, USA.ORCID https://orcid.org/0000-0002-5674-2957
Azza BakkarNYU School of Medicine, New York, NY, USA.ORCID https://orcid.org/0000-0001-8414-2775
Elana Kreiger-BensonNYU School of Medicine, New York, NY, USA.ORCID https://orcid.org/0000-0003-3428-6249
Andrew KumpfbeckNYU School of Medicine, New York, NY, USA.ORCID https://orcid.org/0000-0001-6826-2646
Sam D ShemieMontreal Children's Hospital, McGill University, Montreal, Canada.ORCID https://orcid.org/0000-0002-9776-1257
Gene SungLAC and USC Medical Center, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0001-7439-2359
Sylvia TorranceCanadian Blood Services, Ottawa, Canada.ORCID https://orcid.org/0000-0003-2231-5866
David GreerBoston University School of Medicine, Boston, MA, USA.ORCID https://orcid.org/0000-0002-2026-8333

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

background and purposeWe sought to 1) identify countries in Asia and the Pacific that have protocols for the determination of brain death/death by neurologic criteria (BD/DNC) and 2) review the similarities and differences of these protocols in different countries.

methodsBetween January 2018 and April 2019, we attempted to communicate with contacts in the 57 countries in Asia and the Pacific to determine if they had official national BD/DNC protocols. We reviewed and compared the identified protocols.

resultsWe identified contacts for 40 (70%) of the 57 countries in Asia and the Pacific, and successfully communicated with 37 of them (93% of countries with contacts identified, 65% of countries in Asia and the Pacific). We found that 24 of the 37 countries had BD/DNC protocols. Two (13%) of the 16 protocols that provided a definition of death referred to brainstem death. Kazakhstan and Israel required only 1 examination to declare BD/DNC, while 10 (71%) of the other 14 protocols required 2 examinations separated by 6-48 hours. The prerequisites, clinical examination, apnea testing procedure, and indications for/selection of ancillary tests varied. Ancillary testing was required for all determinations of BD/DNC in five (21%) countries. Thirteen (54%) of the protocols included information about the time of death, while 12 (50%) of them provided instructions about discontinuation of organ support.

conclusionsThe protocols for conducting a BD/DNC determination vary markedly among countries in Asia and the Pacific. Since it is optimal to have internationally and intranationally consistent BD/DNC protocols, efforts should be made to harmonize protocols both within this region and worldwide.

Indexed as

Asiabrain deathdeathpolicy

Identifiers

PMID32657070
PMCPMC7354977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.